On February 10, 2022, CMS announced a national coverage determination that expands coverage for lung cancer screening with low-dose computed tomography (LDCT). This aims to improve health outcomes for people with lung cancer. It expands eligibility for people with Medicare to get lung cancer screening with LCDT in two ways:
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
